Indirect COVID-19 health effects and potential mitigating interventions: Cost-effectiveness framework
- PMID: 35849613
- PMCID: PMC9292069
- DOI: 10.1371/journal.pone.0271523
Indirect COVID-19 health effects and potential mitigating interventions: Cost-effectiveness framework
Abstract
Background: The COVID-19 pandemic led to important indirect health and social harms in addition to deaths and morbidity due to SARS-CoV-2 infection. These indirect impacts, such as increased depression and substance abuse, can have persistent effects over the life course. Estimated health and cost outcomes of such conditions and mitigation strategies may guide public health responses.
Methods: We developed a cost-effectiveness framework to evaluate societal costs and quality-adjusted life years (QALYs) lost due to six health-related indirect effects of COVID-19 in California. Short- and long-term outcomes were evaluated for the adult population. We identified one evidence-based mitigation strategy for each condition and estimated QALYs gained, intervention costs, and savings from averted health-related harms. Model data were derived from literature review, public data, and expert opinion.
Results: Pandemic-associated increases in prevalence across these six conditions were estimated to lead to over 192,000 QALYs lost and to approach $7 billion in societal costs per million population over the life course of adults. The greatest costs and QALYs lost per million adults were due to adult depression. All mitigation strategies assessed saved both QALYs and costs, with five strategies achieving savings within one year. The greatest net savings over 10 years would be achieved by addressing depression ($242 million) and excessive alcohol use ($107 million).
Discussion: The COVID-19 pandemic is leading to significant human suffering and societal costs due to its indirect effects. Policymakers have an opportunity to reduce societal costs and health harms by implementing mitigation strategies.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States.J Med Econ. 2022 Jan-Dec;25(1):605-617. doi: 10.1080/13696998.2022.2071427. J Med Econ. 2022. PMID: 35574613
-
Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.Ann Intern Med. 2021 Jun;174(6):803-810. doi: 10.7326/M21-0510. Epub 2021 Mar 9. Ann Intern Med. 2021. PMID: 33683930 Free PMC article.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 Aug 12;21(13):1-214. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34484487 Free PMC article.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
Cited by
-
Scoping review of modelling studies assessing the impact of disruptions to essential health services during COVID-19.BMJ Open. 2023 Sep 26;13(9):e071799. doi: 10.1136/bmjopen-2023-071799. BMJ Open. 2023. PMID: 37751952 Free PMC article.
-
Experiences Shared by the (Future) Public Health Workforce during the COVD-19 Pandemic in Germany: Results of a Survey on Workload, Work Content, and Related Challenges among Students and Young Professionals.Int J Environ Res Public Health. 2022 Sep 11;19(18):11444. doi: 10.3390/ijerph191811444. Int J Environ Res Public Health. 2022. PMID: 36141717 Free PMC article.
-
Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women.Int J Gen Med. 2023 Sep 27;16:4393-4404. doi: 10.2147/IJGM.S423910. eCollection 2023. Int J Gen Med. 2023. PMID: 37789881 Free PMC article.
-
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis.BMC Public Health. 2023 May 11;23(1):864. doi: 10.1186/s12889-023-15762-0. BMC Public Health. 2023. PMID: 37170225 Free PMC article.
-
Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses.Sci Rep. 2023 Mar 23;13(1):4804. doi: 10.1038/s41598-023-31722-5. Sci Rep. 2023. PMID: 36959228 Free PMC article.
References
-
- Clair R, Gordon M, Kroon M, Reilly C. The effects of social isolation on well-being and life satisfaction during pandemic. Humanit Soc Sci Commun. 2021;8(1). doi: 10.1057/s41599-021-00710-3 - DOI
-
- Berinato S. That Discomfort You’re Feeling Is Grief. Harv Bus Rev. 2020.
-
- Czeisler M, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, et al.. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic—United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1049–57. Epub 2020/08/14. doi: 10.15585/mmwr.mm6932a1 ; PubMed Central PMCID: PMC7440121. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous